Search

Nanoscale zero-valent iron particles (NZVI) produced by using green tea (GT) extract as a reductant can remove Cr(VI) from water effectively, which can be utilized in groundwater remediation. In order to define the reaction mechanism and removal effect in the aquifer, in this study, GT-NZVI particles were prepared and measured by some characterization methods to define their surface performance, and then batch and one-dimensional experiments were carried out to reveal the reaction properties of GT-NZVI and Cr(VI) in groundwater. The results showed that the prepared GT-NZVI particles were regular spherical with a diameter of 10–20 nm, which could disperse in water stably. The main component of GT-NZVI was α-Fe with superficial polyphenols as a stabilizer. GT-NZVI suspension had good ability to reduce the Cr(VI) to Cr(III) in water. When the concentration of GT-NZVI was 1 g/L, the removal efficiency of Cr(VI) with an initial concentration of 100 mg/L reached 92.8% in 1 h reaction. In column tests, GT-NZVI passed through the natural sand column successfully with an average outflow percentage of 71.2%. The simulated in-situ reaction zone (IRZ) with GT-NZVI was used to remediate Cr(VI) contaminated groundwater. The outflow concentration of Cr(VI) kept in 0.14–0.32 mg/L corresponding to the outflow rate below 0.32% within 15 days, and the removal efficiency of Cr(VI) by IRZ with GT-NZVI decreased with the increase of aquifer medium particle size, groundwater flow rate and ionic strength. Most of Cr(III) as reduzate was adsorbed or immobilized on the surface or in the lattice of GT-NZVI, which indicated effective immobilization for chromium.

As there are multiple factors causing hydrocephalus subsequent to intraventricular hemorrhage (IVH), it is difficult to achieve the best treatment effect using a single drug alone. In the present study, the protective effect of combination treatment with granulocyte-colony stimulating factor (G-CSF) and lithium chloride against hydrocephalus after IVH was investigated. A total of 130 adult male Sprague-Dawley rats were divided into five groups, including the IVH control, G-CSF treatment, lithium chloride treatment, combination treatment and sham surgery groups. An IVH rat model was established in order to examine the effect of combination treatment on hydrocephalus incidence. A TUNEL assay was performed to detect neuronal apoptosis in the five groups. In addition, the protein expression levels of B-cell lymphoma 2 (Bcl-2) and Bcl-2-associated X protein (Bax) were detected by western blot analysis. The differentiation of nerve cells in the brain tissue obtained from the five rat groups was also determined with double immunofluorescence staining. The results demonstrated that administration of G-CSF or lithium chloride alone was able to only partly relieve the incidence of hydrocephalus after IVH. By contrast, combination treatment with G-CSF and lithium chloride significantly attenuated the development of hydrocephalus following IVH. TUNEL assay showed that neuronal apoptosis was significantly reduced by the combination treatment with G-CSF and lithium chloride. Furthermore, the expression of Bcl-2 was upregulated, whereas Bax expression was downregulated in the combination treatment group. The results also detected the highest expression of BrdU/GFAP, BrdU/NeuN and BrdU/PSA-NCAM in the combination treatment group. In conclusion, the combination of endogenous neural stem cell mobilization (using G-CSF) and lithium chloride treatment resulted in highly reduced incidence of hydrocephalus after IVH by inhibiting neuronal apoptosis. [ABSTRACT FROM AUTHOR]

The present study aimed to explore molecular mechanisms involved in pituitary adenomas (PAs) and to discover target genes for their treatment. The gene expression profile GSE4488 was downloaded from the Gene Expression Omnibus database. Differentially expressed genes (DEGs) were identified using the Limma package and analyzed by two-dimensional hierarchical clustering. Gene ontology (GO) and pathway enrichment analyses were performed in order to investigate the functions of DEGs. Subsequently, the protein-protein interaction (PPI) network was constructed using Cytoscape software. DEGs were then mapped to the connectivity map database to identify molecular agents associated with the underlying mechanisms of PAs. A total of 340 upregulated and 49 downregulated DEGs in PA samples compared with those in normal controls were identified. Hierarchical clustering analysis showed that DEGs were highly differentially expressed, indicating their aptness for distinguishing PA samples from normal controls. Significant gene ontology terms were positive regulation of immune system-associated processes for downregulated DEGs and skeletal system development for upregulated DEGs. Pathways significantly enriched by DEGs included extracellular matrix (ECM)-receptor interaction, the Hedgehog (Hh) signaling pathway and neuroactive ligand-receptor interaction. The PPI network was constructed with 117 nodes, 123 edges and CD44 and Gli2 as hub nodes. Furthermore, depudecin, a small molecule drug, was identified to be mechanistically associated with PA. The genes CD44 and Gli2 have important roles in the progression of PAs via ECM-receptor interaction and the Hh signaling pathway and are therefore potential target genes of PA. In addition, depudecin may be a candidate drug for the treatment of PAs. [ABSTRACT FROM AUTHOR]